ANDOVER, Mass., Oct. 1, 2021 /PRNewswire/ -- Byrna
Technologies Inc. (NASDAQ: BYRN) ("Byrna" or "the
Company") today announced its support of Susan G. Komen®, the world's
leading breast cancer organization, and Breast Cancer Awareness
Month by offering a limited time product bundle consisting of a
pink-colored Byrna™ SD launcher, a three-year product
warranty, and the Byrna Banshee military-grade, 130dB* personal
safety alarm.
This special package will be available throughout the month of
October exclusively at https://byrna.com/pages/susan-g-komen at a
discounted price of $438.99. Byrna
will donate $30 from the sale of
every pink bundle to Susan G. Komen
in support of its mission to save lives by meeting the most
critical needs in our communities and investing in breakthrough
research that can help prevent and cure breast cancer.
"Byrna is committed to providing solutions that empower people
to Live Safe, a sentiment that aligns quite well with the
mission of Susan G. Komen and its
360-degree approach to fighting breast cancer," said Bryan Ganz, CEO of Byrna. "We work with a group
of amazing women at Byrna, and my own family has been profoundly
affected by breast cancer, so I am pleased to be able to support
the incredible research and good works being done by Susan G. Komen."
About Byrna Technologies Inc.
Byrna is a technology company, specializing in the development,
manufacture, and sale of innovative non-lethal personal security
solutions. For more information on the Company, please visit the
corporate website here or the Company's investor relations site
here. The Company is the manufacturer of the Byrna® HD
personal security device, a state-of-the-art handheld CO2 powered
launcher designed to provide a non-lethal alternative to a firearm
for the consumer, private security, and law enforcement markets. To
purchase Byrna products, visit the Company's e-commerce store
http://www.byrna.com or http://www.amazon.com.
About Susan G. Komen
Susan G. Komen® is the world's leading nonprofit breast cancer
organization, working to save lives and end breast cancer forever.
Komen has an unmatched, comprehensive 360-degree approach to
fighting this disease across all fronts and supporting millions of
people in the U.S. and in countries worldwide. We advocate for
patients, drive research breakthroughs, improve access to
high-quality care, offer direct patient support and empower people
with trustworthy information. Founded by Nancy G. Brinker, who promised her sister,
Susan G. Komen, that she would end
the disease that claimed Suzy's life, Komen remains committed to
supporting those affected by breast cancer today, while tirelessly
searching for tomorrow's cures. Visit komen.org or call 1-877
GO KOMEN. Connect with us on social
at ww5.komen.org/social.
Forward Looking Information
This news release contains "forward-looking statements"
within the meaning of U.S. securities laws. All statements
contained in this news release, other than statements of current
and historical fact, are forward-looking. Often, but not always,
forward-looking statements can be identified by the use of words
such as "plans," "expects," "projects," "intends," "anticipates"
and "believes" and statements that certain actions, events or
results "may," "could," "would," "should," "might," "occur" or "be
achieved" or "will be taken." Forward-looking statements include
descriptions of currently occurring matters which may continue in
the future. Forward looking statements are based on, among other
things, opinions, assumptions, estimates and analyses that, while
considered reasonable by the Company at the date the
forward-looking information is provided, inherently are subject to
significant risks, uncertainties, contingencies, and other factors
that may cause actual results and events to be materially different
from those expressed or implied. Any number of risk factors could
affect our actual results and cause them to differ materially from
those expressed or implied by the forward-looking statements in
this news release. The order in which these factors appear should
not be construed to indicate their relative importance or priority.
We caution that these factors may not be exhaustive; accordingly,
any forward-looking statements contained herein should not be
relied upon as a prediction of actual results. Investors should
carefully consider these and other relevant factors, including
those risk factors in Part I, Item 1A in our most recent Form 10-K,
Item 1A Risk Factors in our most recent Form 10-Q, and subsequent
filings with the Securities and Exchange Commission ("SEC"), should
understand it is impossible to predict or identify all such factors
or risks, should not consider the foregoing list, or the risks
identified in our SEC filings, to be a complete discussion of all
potential risks or uncertainties and should not place undue
reliance on forward-looking information. The Company assumes no
obligation to update or revise any forward-looking information,
except as required by applicable law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/byrna-technologies-supports-susan-g-komen-during-breast-cancer-awareness-month-301389685.html
SOURCE Byrna Technologies Inc.